Captagon

What it is

Captagon is the street name for fenethylline, a synthetic stimulant first developed by Degussa AG in Germany in 1961 and marketed as Biocapton for attention disorders and narcolepsy. Legal production ceased in 1986 when the UN Convention on Psychotropic Substances placed it on Schedule II. Today's illicit tablets are largely counterfeit, typically containing 16-41% amphetamine mixed with caffeine and occasional methamphetamine, pressed with a distinctive double-C logo. Genuine fenethylline metabolizes to roughly 24.5% amphetamine and 13.7% theophylline; the combined effect suppresses fatigue, appetite, and fear. The Gulf Cooperation Council states, particularly Saudi Arabia, account for most consumer demand; secondary markets include Egypt, Lebanon, Jordan, and parts of East Africa.

History

Illicit production first took root in southeastern Europe and Turkey in the 1990s after the pharmaceutical market closed. Syria's civil war, which began in 2011, restructured the trade entirely. The Assad government, led operationally by Maher al-Assad's 4th Armoured Division, placed Syrian military assets and the port of Latakia in the service of industrial-scale export. Lebanon's Bekaa Valley provided a secondary production base, with Hezbollah-affiliated networks documented as distributors. The Syrian conflict gave the regime a captive logistics chain and a revenue rationale to protect production. By 2023, Syria accounted for roughly 80% of global captagon output, generating an estimated US$2.7 billion annually for regime networks. Saudi Arabia alone seized 100 million tablets in five months in 2022. The Arab League's re-engagement with Damascus from 2023 onward explicitly conditioned normalization on dismantling the trade, making captagon a live diplomatic instrument.

Current state

Assad's fall in December 2024 shattered the state production monopoly. Between December 2024 and September 2025, Syria's new authorities dismantled seven industrial laboratories, raided 23 warehouses, and seized over 200 million pills. The 24 June 2026 Homs-Idlib operation arrested two of the most-wanted traffickers and seized 600,000 pills alongside light weapons, RPG rounds, and ammunition. Despite the crackdown, the UNODC's December 2025 research brief found production has fragmented into "non-state entrepreneurialism." Suwayda province in southern Syria, largely beyond Damascus's reach since December 2024, is now the main remaining centre, run by Druze militias, Bedouin tribes, and smuggling families. Jordan struck smuggling hubs across the Suwayda border in May 2026 and, jointly with Syria, seized 5.5 million pills at the Jaber crossing in April 2026. New production nodes have appeared in Yemen (a Houthi-operated laboratory, July 2025), Sudan (four interdictions and one lab bust in 2025), Germany, the Netherlands, and Venezuela. Pill prices have risen sharply as criminal networks lack the logistics Syria's state once supplied.

Relationships

Captagon sits at the intersection of Syria's post-Assad reconstruction, Jordan's border security, Gulf Arab normalization, and the broader shadow economy that fills governance voids. Ahmed al-Sharaa's Damascus government bears the diplomatic cost of captagon's persistence; Gulf states have tied normalization finance to demonstrated results. Jordan is the primary interdiction partner, combining joint operations with Damascus and unilateral airstrikes into Suwayda. Saudi Arabia and the wider Gulf Cooperation Council drive the demand side. Hezbollah-affiliated networks in Lebanon retain logistics and financing roles, complicating enforcement given Beirut's institutional fragility. Europol has documented connections between Middle Eastern captagon supply chains and Italian and Sicilian organized crime groups operating European distribution.

What to watch

• Whether Damascus can extend control into Suwayda, or whether Jordan-assisted operations become the default enforcement mechanism.
• Production migration into Yemen, Libya, and Sudan as Syrian interdiction squeezes the historic supply core.
• Gulf-state financial support for Syrian counter-narcotics as a formal condition of Arab League normalization.
• Bekaa Valley production networks in Lebanon, which retain precursor access and Hezbollah-adjacent logistics even after Assad's fall.
• Price dynamics: sustained high prices will attract new producers, while any price collapse would signal large-scale non-state consolidation of the supply chain.